Anika Reports First Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Anika Therapeutics (ANIK) Tops Q1 EPS by 17c
April 27, 2016 4:06 PM EDTAnika Therapeutics (NASDAQ: ANIK) reported Q1 EPS of $0.45, $0.17 better than the analyst estimate of $0.28. Revenue for the quarter came in at $22.3 million versus the consensus estimate of $19.26 million.
We are off to a strong start in 2016, with total revenue growth of 44% year-over-year... More
